SEC Form D · Amendment · filed March 20, 2019
Orbus Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Elisha (Terry) D. Gould · Palo Alto, CADirectorErnest D. Mario · Palo Alto, CADirectorMichael D. Wasserman · Palo Alto, CADirectorJason D. Levin · Palo Alto, CAExec · DirectorPatrick D. Enright · Palo Alto, CADirectorRobert M. Myers · Palo Alto, CAExec · DirectorRichard Silas · VANCOUVER, British Columbia, CanadaExec · DirectorSusan E. Fasig · Cincinnati, OHExec · DirectorJulie T. Thomas · Cincinnati, OHDirectorGary R. Price · Cincinnati, OHDirectorRick Trotman · VANCOUVER, British Columbia, CanadaDirectorJoseph Gabor · Thornton, PADirectorSharding Management Management LLC · Dover, DEDirectorKingsley Advani · Dover, DEDirectorVilleneuve Robin · Quebec, Quebec, CanadaExec · DirectorJeffrey A. Coopersmith · Columbus, OHDirectorJames L. Hall · Salt Lake City, UTDirectorFrancois Goulet · Montreal, Quebec, CanadaExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗